Amgen (AMGN) Property, Plant & Equipment (Net) (QoQ) (2009 - 2026)

Amgen (AMGN) Property, Plant & Equipment (Net) (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.83%
Dec 31, 2025 9.60%
Sep 30, 2025 5.32%
Jun 30, 2025 2.60%
Mar 31, 2025 2.11%
Dec 31, 2024 6.29%
Sep 30, 2024 0.97%
Jun 30, 2024 1.58%
Mar 31, 2024 1.03%
Dec 31, 2023 6.79%
Sep 30, 2023 0.56%
Jun 30, 2023 1.32%
Mar 31, 2023 0.61%
Dec 31, 2022 4.61%
Sep 30, 2022 0.58%
Jun 30, 2022 0.31%
Mar 31, 2022 -0.81%
Dec 31, 2021 4.05%
Sep 30, 2021 1.55%
Jun 30, 2021 1.05%